Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 923093 STAMFORD, CT

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
15 quarters on record

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Derivatives in ARWR

reported options exposure · as of Jun 30, 2026
CallValue
$1,222,650
CallShares
15,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ARWR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,222,650 15,000
2026-03-31 $200,640 3,200
2026-03-31 $407,550 6,500
2025-12-31 $537,759 8,100
2025-12-31 $796,680 12,000
2025-03-31 $837,119 65,708
2024-12-31 $1,251,572 66,573
2024-09-30 $1,209,152 62,424
2024-03-31 $1,982,838 69,330
2023-12-31 $324,390 10,601
2023-03-31 $1,716,709 67,587
2022-09-30 $1,549,218 46,875
2022-06-30 $741,452 21,058
2022-03-31 $1,896,811 41,244
2021-06-30 $508,514 6,140
2021-03-31 $2,300,824 34,698
2020-03-31 $251,507 8,742